Position in PFE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$136,186,146
+$18,875,623 QoQ
Shares Held
4,849,934
+2.9% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026AVIVA PLC holds $4,673,816,581 across 10 Drug Manufacturers - General names. PFE ranks #8 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
11,087,661 | $2,186,708,502 | |
| 2 | LLY |
ELI LILLY & Co
|
712,581 | $655,410,626 | |
| 3 | JNJ |
Johnson & Johnson
|
2,132,397 | $521,243,122 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,236,573 | $389,327,366 | |
| 5 | ABBV |
AbbVie Inc.
|
1,531,018 | $332,981,104 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,174,576 | $163,700,657 | |
| 7 | AMGN |
Amgen Inc
|
464,183 | $163,322,788 | |
| 8 | PFE |
Pfizer Inc
This page
|
4,849,934 | $136,186,146 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $136,186,146 | 4,849,934 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $117,310,523 | 4,711,266 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $113,660,674 | 4,460,780 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $102,769,309 | 4,239,658 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $100,362,820 | 3,960,648 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $90,569,201 | 3,413,841 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $99,732,246 | 3,446,173 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $94,175,587 | 3,365,818 | Shares | Defined | 2024-08-02 | |
| 2024-03-31 | $75,243,237 | 2,711,468 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $84,826,452 | 2,946,386 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $92,400,408 | 2,785,662 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $106,223,115 | 2,895,941 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $94,921,444 | 2,326,506 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $116,055,166 | 2,264,933 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $86,028,615 | 1,965,919 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $99,404,029 | 1,895,938 | Shares | Defined | 2022-08-04 | |
| 2022-03-31 | $73,387,805 | 1,417,574 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $51,483,037 | 871,855 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $44,749,582 | 1,040,446 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $72,951,594 | 1,862,911 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $72,087,012 | 1,989,705 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $73,391,593 | 1,993,795 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $67,812,967 | 1,947,546 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $62,767,559 | 2,023,148 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $65,226,213 | 2,106,266 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||